Goldman Sachs MSCI World Private Equity Return Tracker ETF (GTPE)
| Assets | $25.39M |
| Expense Ratio | 0.50% |
| PE Ratio | n/a |
| Shares Out | 500,000 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Ratio | n/a |
| 1-Year Return | n/a |
| Volume | 33 |
| Open | 51.32 |
| Previous Close | 51.02 |
| Day's Range | 51.32 - 51.32 |
| 52-Week Low | 47.70 |
| 52-Week High | 51.45 |
| Beta | n/a |
| Holdings | 1634 |
| Inception Date | Oct 21, 2025 |
About GTPE
Fund Home PageThe Goldman Sachs MSCI World Private Equity Return Tracker ETF (GTPE) is an exchange-traded fund that mostly invests in total market equity. The fund is not private equity, it is attempting to replicate the performance returns of the space. The fund aims to track an index which comprises long and short positions in publicly listed stocks, globally GTPE was launched on Oct 21, 2025 and is issued by Goldman Sachs.
Top 10 Holdings
102.61% of assets| Name | Symbol | Weight |
|---|---|---|
| 11/17/2026 12:00:00 AM-SDB764413180-EQSWAP | -- | 44.68% |
| 11/17/2026 12:00:00 AM-SDB764413181-EQSWAP | -- | 25.95% |
| US DOLLAR | USD | 18.00% |
| Broadcom Inc. | AVGO | 2.25% |
| Palantir Technologies Inc. | PLTR | 2.13% |
| Eli Lilly and Company | LLY | 2.10% |
| GE Vernova Inc. | GEV | 2.01% |
| Vertex Pharmaceuticals Incorporated | VRTX | 1.90% |
| Microsoft Corporation | MSFT | 1.89% |
| Bristol-Myers Squibb Company | BMY | 1.70% |
News
Goldman Sachs Asset Management Adds New Private Equity ETF
In the latest move in the ever changing ETF landscape, Goldman Sachs Asset Management has launched a new ETF. The firm, which currently offers a suite of ETFs featuring premium income offerings, will ...
Private Equity Had a Great Story. Investors May Be Tired of Hearing It.
Despite the common moniker, much of the recent success has been built around a boom in private credit as opposed to equity. There are signs that the trend has entered its baroque period.